-
Something wrong with this record ?
Importance of tumour suppressor gene methylation in sinonasal carcinomas
M. Chmelařová, I. Sirák, M. Mžik, K. Sieglová, H. Vošmiková, P. Dundr, K. Němejcová, J. Michálek, M. Vošmik, V. Palička, J. Laco
Language English Country Czech Republic
Document type Journal Article
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Enzyme Activation MeSH
- DNA (Cytosine-5-)-Methyltransferases genetics metabolism MeSH
- Epigenomics MeSH
- Cadherins genetics metabolism MeSH
- Humans MeSH
- DNA Methylation * MeSH
- Head and Neck Neoplasms diagnosis genetics physiopathology virology MeSH
- Papillomaviridae isolation & purification MeSH
- Prognosis MeSH
- Promoter Regions, Genetic genetics MeSH
- Carcinoma, Squamous Cell diagnosis genetics physiopathology virology MeSH
- Genes, Tumor Suppressor * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Epigenetic changes are considered to be a frequent event during tumour development. Hypermethylation of promoter CpG islands represents an alternative mechanism for inactivation of tumour suppressor genes, DNA repair genes, cell cycle regulators and transcription factors. The aim of this study was to investigate promoter methylation of specific genes in samples of sinonasal carcinoma by comparison with normal sinonasal tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) to compare the methylation status of 64 tissue samples of sinonasal carcinomas with 19 control samples. We also compared the human papilloma virus (HPV) status with DNA methylation. Using a 20% cut-off for methylation, we observed significantly higher methylation in RASSF1, CDH13, ESR1 and TP73 genes in the sinonasal cancer group compared with the control group. HPV positivity was found in 15/64 (23.4 %) of all samples in the carcinoma group and in no sample in the control group. No correlation was found between DNA methylation and HPV status. In conclusion, our study showed that there are significant differences in promoter methylation in the RASSF1, ESR 1, TP73 and CDH13 genes between sinonasal carcinoma and normal sinonasal tissue, suggesting the importance of epigenetic changes in these genes in carcinogenesis of the sinonasal area. These findings could be used as prognostic factors and may have implications for future individualised therapies based on epigenetic changes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17010397
- 003
- CZ-PrNML
- 005
- 20170330083159.0
- 007
- ta
- 008
- 170320s2016 xr d f 000 0|eng||
- 009
- AR
- 024 __
- $a 10.14712/fb2016062030110 $2 doi
- 035 __
- $a (PubMed)27516190
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Chmelařová, Marcela, $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $d 1985- $7 xx0191598
- 245 10
- $a Importance of tumour suppressor gene methylation in sinonasal carcinomas / $c M. Chmelařová, I. Sirák, M. Mžik, K. Sieglová, H. Vošmiková, P. Dundr, K. Němejcová, J. Michálek, M. Vošmik, V. Palička, J. Laco
- 520 9_
- $a Epigenetic changes are considered to be a frequent event during tumour development. Hypermethylation of promoter CpG islands represents an alternative mechanism for inactivation of tumour suppressor genes, DNA repair genes, cell cycle regulators and transcription factors. The aim of this study was to investigate promoter methylation of specific genes in samples of sinonasal carcinoma by comparison with normal sinonasal tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) to compare the methylation status of 64 tissue samples of sinonasal carcinomas with 19 control samples. We also compared the human papilloma virus (HPV) status with DNA methylation. Using a 20% cut-off for methylation, we observed significantly higher methylation in RASSF1, CDH13, ESR1 and TP73 genes in the sinonasal cancer group compared with the control group. HPV positivity was found in 15/64 (23.4 %) of all samples in the carcinoma group and in no sample in the control group. No correlation was found between DNA methylation and HPV status. In conclusion, our study showed that there are significant differences in promoter methylation in the RASSF1, ESR 1, TP73 and CDH13 genes between sinonasal carcinoma and normal sinonasal tissue, suggesting the importance of epigenetic changes in these genes in carcinogenesis of the sinonasal area. These findings could be used as prognostic factors and may have implications for future individualised therapies based on epigenetic changes.
- 650 _2
- $a kadheriny $x genetika $x metabolismus $7 D015820
- 650 _2
- $a spinocelulární karcinom $x diagnóza $x genetika $x patofyziologie $x virologie $7 D002294
- 650 _2
- $a DNA-(cytosin-5-)methyltransferasa $x genetika $x metabolismus $7 D004248
- 650 12
- $a metylace DNA $7 D019175
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a epigenomika $7 D057890
- 650 12
- $a tumor supresorové geny $7 D016147
- 650 _2
- $a nádory hlavy a krku $x diagnóza $x genetika $x patofyziologie $x virologie $7 D006258
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Papillomaviridae $x izolace a purifikace $7 D027383
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a promotorové oblasti (genetika) $x genetika $7 D011401
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sirák, Igor $u Department of Oncology and Radiotherapy, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $7 xx0135409
- 700 1_
- $a Mžik, Martin $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $7 xx0262461
- 700 1_
- $a Sieglová, K. $u The Fingerland Department of Pathology, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $7 _AN090898
- 700 1_
- $a Vošmiková, Hana $u The Fingerland Department of Pathology, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $7 xx0228321
- 700 1_
- $a Dundr, Pavel $u Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0080436
- 700 1_
- $a Němejcová, Kristýna $u Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0233214
- 700 1_
- $a Michálek, Jaroslav $u Department of Clinical and Molecular Pathology, Palacký University Olomouc, Faculty of Medicine and Dentistry and University Hospital Olomouc, Czech Republic $7 xx0230514
- 700 1_
- $a Vošmik, Milan, $u Department of Oncology and Radiotherapy, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $d 1972- $7 xx0135408
- 700 1_
- $a Palička, Vladimír, $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $d 1946- $7 jn99240000830
- 700 1_
- $a Laco, Jan, $u The Fingerland Department of Pathology, Charles University in Prague - Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic $d 1979- $7 xx0051050
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 62, č. 3 (2016), s. 110-119
- 856 41
- $u http://fb.cuni.cz/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20170320 $b ABA008
- 991 __
- $a 20170329100225 $b ABA008
- 999 __
- $a ok $b bmc $g 1196581 $s 971113
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 62 $c 3 $d 110-119 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20170320